Establishment Labs Holdings Inc (ESTA)
42.61
+0.80
(+1.91%)
USD |
NASDAQ |
Nov 21, 16:00
42.72
+0.11
(+0.26%)
After-Hours: 20:00
Establishment Labs Holdings Total Liabilities (Quarterly): 249.98M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 249.98M |
June 30, 2024 | 240.07M |
March 31, 2024 | 244.93M |
December 31, 2023 | 250.25M |
September 30, 2023 | 240.05M |
June 30, 2023 | 230.43M |
March 31, 2023 | 225.36M |
December 31, 2022 | 219.25M |
September 30, 2022 | 186.13M |
June 30, 2022 | 184.02M |
March 31, 2022 | 93.72M |
December 31, 2021 | 88.79M |
September 30, 2021 | 86.80M |
June 30, 2021 | 83.29M |
Date | Value |
---|---|
March 31, 2021 | 79.80M |
December 31, 2020 | 81.43M |
September 30, 2020 | 74.73M |
June 30, 2020 | 75.03M |
March 31, 2020 | 78.12M |
December 31, 2019 | 76.92M |
September 30, 2019 | 74.45M |
June 30, 2019 | 51.01M |
March 31, 2019 | 47.93M |
December 31, 2018 | 47.09M |
September 30, 2018 | 44.48M |
June 30, 2018 | 60.95M |
March 31, 2018 | 67.78M |
December 31, 2017 | 62.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
74.73M
Minimum
Sep 2020
250.25M
Maximum
Dec 2023
154.45M
Average
138.87M
Median
Total Liabilities (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 76.47B |
Cassava Sciences Inc | 57.11M |
Aytu BioPharma Inc | 86.00M |
enVVeno Medical Corp | 3.02M |
Onconetix Inc | 88.19M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 282.68M |
Shareholders Equity (Quarterly) | 32.71M |
Debt to Equity Ratio | 5.942 |
Current Ratio | 3.623 |
Net Debt Paydown Yield | -0.20% |